Moderna 8-K
Leadership change
Juan Andres appointed COO to lead manufacturing for a potential intismeran autogene launch and oncology expansion
Filed 2026-09-30 07:15 ET
- 5.02 Officer/director change
- 7.01 Regulation FD Disclosure
- 9.01 Financial Statements and Exhibits
Summary
Moderna appointed Juan Andres as COO and announced the retirement of Chief Technical Operations and Quality Officer Jerh Collins. Andres’s appointment is effective 10/05/2026; he will lead manufacturing, report to CEO Stéphane Bancel and serve on the Executive Committee. The new role is intended to support company growth and diversification, including a potential launch and scale-up of intismeran autogene and expansion of the oncology portfolio.
Key Figures
- Andres’s annual base salary is $0.8M, with a 2026 prorated cash bonus and a 90% annual incentive target based on individual and/or company goals.
- New-hire equity award target: $5M, subject to a four-year vesting period; no more than 75% may be delivered as restricted stock units.
- Future annual equity award target: $4M-$5M, subject to Compensation Committee approval and adjustment.
The summary is written by an AI model reading the filing.
Model 005 · prompt 01d34d48e3